Use of remimazolam as an adjunct to general anesthesia for an adolescent with MELAS syndrome.

Use of remimazolam as an adjunct to general anesthesia for an adolescent with MELAS syndrome.

MELAS syndrome is an acronym so named because of the characteristic clinical and pathophysiologic features including mitochondrial encephalo-myopathy, lactic aci- dosis, and stroke-like episodes. As the disorder impacts mitochondrial function and oxidative phosphorylation, clinical symptoms characte...

Full description

Bibliographic Details
Main Authors: N. Gyurgyik, J. Warren, R. Miketic, J. D. Tobias
Format: Article
Language:English
Published: Pediatric Anesthesia and Critical Care Journal 2022-10-01
Series:Pediatric Anesthesia and Critical Care Journal (PACCJ)
Subjects:
mitochondrial myopathy
oxidative phosphorylation
melas syndrome
Online Access:http://www.anestesiarianimazione.com/PACCJ%202022/Use%20of%20remimazolam%20as%20an%20adjunct%20to%20general%20anesthesia%20for%20an%20adolescent%20with%20MELAS%20syndrome.pdf

Internet

http://www.anestesiarianimazione.com/PACCJ%202022/Use%20of%20remimazolam%20as%20an%20adjunct%20to%20general%20anesthesia%20for%20an%20adolescent%20with%20MELAS%20syndrome.pdf

Similar Items